NCT00603772View on ClinicalTrials.gov

Clinical Evaluation of the Photoallergy Potential of Atralin Gel

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Healthy
Interventions
DRUG

Atralin (tretinoin) gel, 0.05%

Assess photoallergic reactions for tretinoin 0.05% and vehicle, measured as skin reactions following induction and challenge.

Trial Locations (1)

27106

Suncare Research Laboratories, Winston-Salem

Sponsors
All Listed Sponsors
lead

Coria Laboratories, Ltd.

INDUSTRY